Status: current, Defined. Date: 30-Apr 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3282941000168113 | alogliptin 12.5 mg + metformin hydrochloride 850 mg tablet, 20 tablets (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3282951000168110 | alogliptin 12.5 mg + metformin hydrochloride 850 mg tablet, 20 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| alogliptin 12.5 mg + metformin hydrochloride 850 mg tablet, 20 tablets (medicinal product pack) | Is a | metformin hydrochloride 850 mg tablet, 20 | true | Inferred relationship | Some | ||
| alogliptin 12.5 mg + metformin hydrochloride 850 mg tablet, 20 tablets (medicinal product pack) | has MPUU | alogliptin 12.5 mg + metformin hydrochloride 850 mg tablet | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Vipdomet 12.5/850 tablet, 20 | Is a | True | alogliptin 12.5 mg + metformin hydrochloride 850 mg tablet, 20 tablets (medicinal product pack) | Inferred relationship | Some | |
| Nesina Met 12.5 mg/850 mg tablet, 20 | Is a | True | alogliptin 12.5 mg + metformin hydrochloride 850 mg tablet, 20 tablets (medicinal product pack) | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR